BlackRock Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.86M | Sell |
293,567
-1,453
| -0.5% | -$9.2K | ﹤0.01% | 2264 |
|
|
2016
Q3 | $1.3M | Buy |
295,020
+17,000
| +6% | +$75K | ﹤0.01% | 2477 |
|
|
2016
Q2 | $790K | Buy |
278,020
+16,483
| +6% | +$46.8K | ﹤0.01% | 2782 |
|
|
2016
Q1 | $740K | Buy |
261,537
+3,855
| +1% | +$10.9K | ﹤0.01% | 2680 |
|
|
2015
Q4 | $2.66M | Buy |
257,682
+2
| +0% | +$21 | ﹤0.01% | 1879 |
|
|
2015
Q3 | $2.94M | Sell |
257,680
-20,717
| -7% | -$236K | ﹤0.01% | 1762 |
|
|
2015
Q2 | $4.16M | Buy |
278,397
+51,262
| +23% | +$765K | 0.01% | 1643 |
|
|
2015
Q1 | $2.05M | Buy |
227,135
+2,771
| +1% | +$25K | ﹤0.01% | 2002 |
|
|
2014
Q4 | $2.73M | Sell |
224,364
-2,211
| -1% | -$26.9K | ﹤0.01% | 1798 |
|
|
2014
Q3 | $2.22M | Buy |
226,575
+2,024
| +0.9% | +$19.8K | ﹤0.01% | 1917 |
|
|
2014
Q2 | $2.86M | Buy |
+224,551
| New | +$2.86M | ﹤0.01% | 1790 |
|